Clinical trial
Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous…
NCT00084890 · Wake Forest University Health Sciences, Other · Terminated
Key facts
| NCT number | NCT00084890 |
|---|---|
| Title | Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix |
| Official title | Weekly Docetaxel and Carboplatin in Patients With Recurrent Squamous Carcinoma of the Cervix: A Phase I/II Study |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel |
| Enrollment | 15 |
| Start date | Nov 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Apr 1, 2010 |
| First posted | Jun 11, 2004 |
| Last update posted | Aug 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: